Accurate taxonomic classification is foundational for microbiome research, clinical diagnostics, and drug development.
Achieving species-level resolution in microbiome data is a critical frontier for unlocking the full potential of microbiome research in drug discovery and therapeutic development.
Accurate profiling of microbial communities via 16S rRNA gene sequencing is fundamentally dependent on primer selection, a choice that introduces significant bias and influences all downstream conclusions.
Next-generation sequencing (NGS) has revolutionized our ability to study the vast majority of microorganisms that cannot be cultivated in the laboratory.
Homology-Directed Repair (HDR) is essential for precise CRISPR-based knock-ins but remains a major bottleneck due to its low efficiency compared to error-prone repair pathways.
This article provides a detailed examination of strategies to control Cas9 expression for the purpose of minimizing off-target effects in CRISPR-Cas9 genome editing.
This comprehensive guide details optimized ribonucleoprotein (RNP) transfection protocols for CRISPR genome editing, tailored for researchers and drug development professionals.
This article provides a comprehensive analysis of ex vivo and in vivo CRISPR-Cas9 delivery strategies for therapeutic applications.
This article provides a comprehensive analysis of how local chromatin accessibility fundamentally influences the efficiency of CRISPR-Cas9 gene editing.
This guide provides a comprehensive, up-to-date framework for researchers and drug development professionals to diagnose, troubleshoot, and validate low CRISPR-Cas9 knockout efficiency.